Brii Biosciences
Beijing · Founded 2018
About Brii Biosciences
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $500K – $1M
- Total funding: $415.0M
- Funding stage: IPO
- Last round: Series C (Mar 2021)
- Ticker: fra:7SS
- Website: briibio.com
- Phone: (919) 240-5605
Industries & Categories
Biotechnology, Health Care, Innovation Management, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/brii-biosciences-72550 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.